Christopher P. Hill

16.6k total citations · 3 hit papers
138 papers, 13.3k citations indexed

About

Christopher P. Hill is a scholar working on Molecular Biology, Cell Biology and Virology. According to data from OpenAlex, Christopher P. Hill has authored 138 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Molecular Biology, 43 papers in Cell Biology and 22 papers in Virology. Recurrent topics in Christopher P. Hill's work include Ubiquitin and proteasome pathways (38 papers), HIV Research and Treatment (22 papers) and Endoplasmic Reticulum Stress and Disease (21 papers). Christopher P. Hill is often cited by papers focused on Ubiquitin and proteasome pathways (38 papers), HIV Research and Treatment (22 papers) and Endoplasmic Reticulum Stress and Disease (21 papers). Christopher P. Hill collaborates with scholars based in United States, United Kingdom and Denmark. Christopher P. Hill's co-authors include Wesley I. Sundquist, Frank G. Whitby, Heidi Schubert, David K. Worthylake, Sanghee Yoo, Howard Robinson, Linda Hicke, Martin Rechsteiner, David Eisenberg and F.F. Vajdos and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Christopher P. Hill

136 papers receiving 13.2k citations

Hit Papers

Ubiquitin-binding domains 1996 2026 2006 2016 2005 1996 1997 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Christopher P. Hill 10.0k 3.0k 2.8k 1.7k 1.7k 138 13.3k
Kunio Nagashima 6.0k 0.6× 3.8k 1.3× 1.3k 0.5× 2.3k 1.3× 1.7k 1.0× 265 12.2k
Paul T. Wingfield 9.8k 1.0× 2.6k 0.9× 1.1k 0.4× 2.3k 1.3× 2.3k 1.3× 238 16.5k
Charles S. Craik 10.6k 1.1× 1.2k 0.4× 1.2k 0.4× 2.3k 1.3× 2.0k 1.2× 344 19.6k
Laurence Florens 18.2k 1.8× 1.5k 0.5× 2.4k 0.9× 893 0.5× 1.7k 1.0× 266 23.9k
David G. Myszka 9.1k 0.9× 1.3k 0.4× 1.4k 0.5× 1.0k 0.6× 781 0.5× 133 13.2k
Hanswalter Zentgraf 7.9k 0.8× 1.1k 0.4× 1.7k 0.6× 796 0.5× 2.5k 1.5× 226 14.1k
James M. Berger 12.1k 1.2× 1.3k 0.4× 785 0.3× 1.4k 0.8× 740 0.4× 164 15.2k
E. Yvonne Jones 10.2k 1.0× 1.9k 0.6× 2.1k 0.8× 2.4k 1.4× 1.8k 1.0× 282 22.5k
Pauline M. Rudd 21.1k 2.1× 1.5k 0.5× 2.0k 0.7× 1.3k 0.7× 1.3k 0.8× 353 28.9k
Terry D. Copeland 6.8k 0.7× 1.8k 0.6× 699 0.2× 1.4k 0.8× 916 0.5× 92 10.2k

Countries citing papers authored by Christopher P. Hill

Since Specialization
Citations

This map shows the geographic impact of Christopher P. Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Hill more than expected).

Fields of papers citing papers by Christopher P. Hill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher P. Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Hill. The network helps show where Christopher P. Hill may publish in the future.

Co-authorship network of co-authors of Christopher P. Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher P. Hill. A scholar is included among the top collaborators of Christopher P. Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher P. Hill. Christopher P. Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Whitby, Frank G., et al.. (2025). Protein chirality as a determinant of ligand affinity: insights from l - and d -streptavidin. Chemical Science. 16(48). 23342–23350.
3.
Schubert, Heidi, et al.. (2025). The structure of full-length AFPK supports the ACP linker in a role that regulates iterative polyketide and fatty acid assembly. Proceedings of the National Academy of Sciences. 122(6). e2419884122–e2419884122. 2 indexed citations
4.
Goodell, Dayton J., Frank G. Whitby, Jerry E. Mellem, et al.. (2024). Mechanistic and structural studies reveal NRAP-1-dependent coincident activation of NMDARs. Cell Reports. 43(2). 113694–113694. 1 indexed citations
5.
Schubert, Heidi, et al.. (2024). Visualization of the Cdc48 AAA+ ATPase protein unfolding pathway. Nature Communications. 15(1). 7505–7505. 4 indexed citations
6.
Skalicky, Jack J., Frank G. Whitby, Douglas R. Mackay, et al.. (2023). The Calpain-7 protease functions together with the ESCRT-III protein IST1 within the midbody to regulate the timing and completion of abscission. eLife. 12. 5 indexed citations
7.
Jami‐Alahmadi, Yasaman, Frank G. Whitby, James A. Wohlschlegel, et al.. (2023). Direct tests of cytochrome c and c 1 functions in the electron transport chain of malaria parasites. Proceedings of the National Academy of Sciences. 120(19). e2301047120–e2301047120. 10 indexed citations
8.
Xiong, Xiaochun, Jin Hwan Kim, John G. Menting, et al.. (2022). Symmetric and asymmetric receptor conformation continuum induced by a new insulin. Nature Chemical Biology. 18(5). 511–519. 30 indexed citations
9.
Parnell, Timothy J., et al.. (2021). The interaction between the Spt6-tSH2 domain and Rpb1 affects multiple functions of RNA Polymerase II. Nucleic Acids Research. 50(2). 784–802. 5 indexed citations
10.
Liu, Li, Manshu Tang, Rajan Pragani, et al.. (2021). Structure-Based Optimization of Small Molecule Human Galactokinase Inhibitors. Journal of Medicinal Chemistry. 64(18). 13551–13571. 4 indexed citations
11.
Qin, Zhao, Helen H. Kang, Frank G. Whitby, et al.. (2021). Peptoid Residues Make Diverse, Hyperstable Collagen Triple-Helices. Journal of the American Chemical Society. 143(29). 10910–10919. 37 indexed citations
12.
Chun, Yujin, Yoo Jin Joo, Hyunsuk Suh, et al.. (2019). Selective Kinase Inhibition Shows That Bur1 (Cdk9) Phosphorylates the Rpb1 Linker In Vivo. Molecular and Cellular Biology. 39(15). 19 indexed citations
13.
Xiong, Xiaochun, Michael A. VandenBerg, Frank G. Whitby, et al.. (2019). Novel four-disulfide insulin analog with high aggregation stability and potency. Chemical Science. 11(1). 195–200. 26 indexed citations
14.
McCullough, John, Robert D. Fisher, Frank G. Whitby, Wesley I. Sundquist, & Christopher P. Hill. (2008). ALIX-CHMP4 interactions in the human ESCRT pathway. Proceedings of the National Academy of Sciences. 105(22). 7687–7691. 190 indexed citations
15.
Macbeth, Mark R., et al.. (2005). Inositol Hexakisphosphate Is Bound in the ADAR2 Core and Required for RNA Editing. Science. 309(5740). 1534–1539. 338 indexed citations
16.
Förster, Andreas, E.I. Masters, Frank G. Whitby, Howard Robinson, & Christopher P. Hill. (2005). The 1.9 Å Structure of a Proteasome-11S Activator Complex and Implications for Proteasome-PAN/PA700 Interactions. Molecular Cell. 18(5). 589–599. 188 indexed citations
17.
Schubert, Heidi, John D. Phillips, & Christopher P. Hill. (2003). Structures along the Catalytic Pathway of PrmC/HemK, an N 5 -Glutamine AdoMet-Dependent Methyltransferase. Biochemistry. 42(19). 5592–5599. 51 indexed citations
18.
VanDemark, Andrew P. & Christopher P. Hill. (2002). SUMO Wrestling with Specificity. Structure. 10(3). 281–282. 4 indexed citations
19.
Whitby, Frank G., et al.. (2000). Structural Basis for the Activation of Proteasomes by 11S Regulators. Nature. 408. 2 indexed citations
20.
Gamble, Theresa, F.F. Vajdos, Sanghee Yoo, et al.. (1996). Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid. Cell. 87(7). 1285–1294. 597 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026